Project Details
Abstract
Nasopharyngeal carcinoma (NPC) is a malignant tumor originated from squamous epithelium.
Numerous genetic aberrations have been detected in NPC, including activation of oncogenes
and inactivation of tumor suppressor genes (TSGs). Inactivation of TSGs by DNA
methylation, has become an important mechanism in tumorigenesis. Our previous work
indicated that DNA methyltransferase (DNMT) expression is elevated in NPC tumor when
compared with adjacent non-tumor suggesting DNA hypermethylation may be critical in NPC
pathogenesis. In cancer cells, aberrant DNAmethylation in promoter region often correlates
with the inactivation or silencing of the TSG. Hence, gene targets of DNMT may be
considered as TSG candidates. Besides coding cellular genes, the expression of non-coding
microRNA (miR) genes can also be repressed by DNAmethylation. As each miRs is a
negative translational regulator of 800~1000 cellular mRNAs, aberrant deregulation of
TSG-miRs (miRs that negatively regulate oncogenes) due to DNAmethylation may lead to
promotion of cancerous phenotype. Taken together, the specific aims of this proposal are (1)
to identify and validate the methylation status of potential hypermethylated genes including
tumor suppressor genes and miRs in NPC cell lines; (2) to identify the gene targets of
hypermethylated miRs in NPC cells; (3) to examine the biological functions of these
hypermethylated miR genes and miR downstream gene targets, and their roles in NPC
tumorigenesis.
Project IDs
Project ID:PA10007-0795
External Project ID:NSC100-2311-B182-004
External Project ID:NSC100-2311-B182-004
Status | Finished |
---|---|
Effective start/end date | 01/08/11 → 31/07/12 |
Keywords
- Nasopharyngeal carcinoma
- microRNA (miRNA)
- DNA methylation
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.